Andrew R. Robbins - 25 Jan 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
President and CEO, Director
Signature
/s/ Ryan Murr, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
25 Jan 2022
Transactions value $
$3,410,808
Form type
4
Date filed
27 Jan 2022, 16:37
Previous filing
14 May 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $3.41M +690K $4.94 690K 25 Jan 2022 Common Stock 690K $7.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.